The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

The Cancer Drug Development Forum (CDDF) is delighted to announce that its executive summary of the CDDF workshop on Biomarkers in Precision Oncology (13-14 Nov 2023, NL) has been published and is available to all our stakeholders.

This insightful workshop brought together the community of cancer research to discuss how biomarker use could best be implemented in drug development. With our speakers and audience with diverse backgrounds, it generated fruitful discussions and interactive dialogue, placing strong emphasis on collaboration among all stakeholders.

Read the executive summary 📜 to learn more about our discussions and watch the video 📺 to get a glimpse of the workshop.

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70